May 9 (Reuters) - Menlo Therapeutics Inc:
* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* LOWERING ITS OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2018 TO A RANGE OF APPROXIMATELY $68.0 MILLION TO $78.0 MILLION Source text for Eikon: Further company coverage: